Prosight Management, LP
CIK 0001617201 · DALLAS, TX · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$580.4M
2026 Q2
Positions
36
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
70.7%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
LKFT
LAKEFRONT BIOTHERAPEUTICS NV
10.6%
JANX
JANUX THERAPEUTICS INC
10.1%
NKTR
NEKTAR THERAPEUTICS
9.7%
BSX
BOSTON SCIENTIFIC CORP
9.3%
STTK
SHATTUCK LABS INC
7.1%
INSM
INSMED INC
6.9%
ALNY
ALNYLAM PHARMACEUTICALS INC
5.1%
SNDX
SYNDAX PHARMACEUTICALS INC
4.5%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.